Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Impax Challenges Abbott’s Patents in Connection to Tricor
Nov. 2, 2009
Impax Laboratories, Inc. has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR (fenofibrate) tablets, 48
mg and 145 mg.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing